Stay updated on KPI-121 vs Placebo in Dry Eye: Safety/Efficacy Clinical Trial

Sign up to get notified when there's something new on the KPI-121 vs Placebo in Dry Eye: Safety/Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KPI-121 vs Placebo in Dry Eye: Safety/Efficacy Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and older notices were removed, indicating routine site maintenance with no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-11T14:16:51.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding lapse and current operating status with links to cc.nih.gov and opm.gov. Updated the site revision to v3.4.1, replacing v3.4.0.
    Difference
    0.3%
    Check dated 2026-02-04T10:25:11.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and introduced new metadata fields such as 'Last Update Submitted that Met QC Criteria' and a revision notice (Revision: v3.4.0). The previous labels and capitalization variants, like 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data', were updated or removed.
    Difference
    0.1%
    Check dated 2026-01-28T06:20:33.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no study data or core content appears to be altered.
    Difference
    0.0%
    Check dated 2026-01-14T03:20:19.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    New study locations across Alabama, Arizona, Arkansas, California, Florida, Georgia, Illinois, Indiana, Kentucky, Massachusetts, Minnesota, Missouri, Nevada, New York, North Carolina, Ohio, Oregon, Pennsylvania, Tennessee, Texas, Utah, Virginia, Washington, and West Virginia were added (v3.3.3). Entries removed include the previous state locations (v3.3.2) and the HHS Vulnerability Disclosure link.
    Difference
    2%
    Check dated 2025-12-23T13:39:45.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is displayed, replacing the previous v3.3.1. This appears to be a minor internal update with no changes to study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:43:29.000Z thumbnail image

Stay in the know with updates to KPI-121 vs Placebo in Dry Eye: Safety/Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KPI-121 vs Placebo in Dry Eye: Safety/Efficacy Clinical Trial page.